Interesting perspective. One question we'll increasingly have to ask is whether longevity tourism can also become sustainable. Frequent long-haul travel has an environmental cost, and planetary health ultimately influences human health too. Perhaps the long-term goal is to make high-quality preventive care accessible closer to where people live, rather than requiring people to travel thousands of kilometres.
The line that stays with me is that the marketing is identical whether the intervention has strong evidence or none - that’s the whole problem in one sentence. Your four-tier framework is useful precisely because the patient can’t see the tiers; the spa menu and the stem-cell injection are sold in the same font.
I’d add one thing from the demand side: the reason the marketing works is that the underlying science is real enough to be borrowed. A genuine finding about diagnostics or NAD+ gets stretched to cover a $25k procedure it never supported, and by the time it reaches the consumer, the distance between “promising” and “proven” has quietly closed. That translation gap is most of what I write about. Supervision and continuity fix the delivery but someone also has to fix what the patient was told before they ever booked the flight.
Lovely taxonomy of longevity tourism, and a very useful distinction between health travel as an ancient human instinct and medicalized luxury as a modern risk. So if a restorative environment becomes a medical promise, what level of evidence, supervision, and accountability should accompany it?
Interesting perspective. One question we'll increasingly have to ask is whether longevity tourism can also become sustainable. Frequent long-haul travel has an environmental cost, and planetary health ultimately influences human health too. Perhaps the long-term goal is to make high-quality preventive care accessible closer to where people live, rather than requiring people to travel thousands of kilometres.
The line that stays with me is that the marketing is identical whether the intervention has strong evidence or none - that’s the whole problem in one sentence. Your four-tier framework is useful precisely because the patient can’t see the tiers; the spa menu and the stem-cell injection are sold in the same font.
I’d add one thing from the demand side: the reason the marketing works is that the underlying science is real enough to be borrowed. A genuine finding about diagnostics or NAD+ gets stretched to cover a $25k procedure it never supported, and by the time it reaches the consumer, the distance between “promising” and “proven” has quietly closed. That translation gap is most of what I write about. Supervision and continuity fix the delivery but someone also has to fix what the patient was told before they ever booked the flight.
Really sharp piece.
Lovely taxonomy of longevity tourism, and a very useful distinction between health travel as an ancient human instinct and medicalized luxury as a modern risk. So if a restorative environment becomes a medical promise, what level of evidence, supervision, and accountability should accompany it?